AnMed Cancer Center
Anderson, South Carolina, United States
Cancer treatment center in Anderson, South Carolina
2000 E Greenville St Suite 5130, Anderson, SC 29621
About AnMed Cancer Center
"At AnMed Health Cancer Center, state-of-the-art technology and expert outpatient care are combined to provide nationally-recognized treatment. The Cancer Center offers a range of diagnostic and treatment services, including radiation therapy, infusion, chemotherapy and 3D mammography."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at AnMed Cancer Center
During the past decade, AnMed Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 46 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
2008-07-01
2009-10-01
Completed
405
Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
2009-02-12
2011-01-12
Terminated
2,720
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
2011-06-01
2012-06-01
Completed
46
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
2011-07-01
2013-10-01
Completed
922
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
2011-11-01
2013-01-01
Completed
345
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AnMed Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 37 trials, followed by "SWOG Cancer Research Network" with 31 trials
sponsored, "NSABP Foundation Inc" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 3 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AnMed Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at AnMed Cancer Center
According to Clinical.Site data, the most researched conditions in "AnMed Cancer Center" are
"Breast Cancer" (21 trials), "Lung Cancer" (13 trials), "Lymphoma" (12 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (8 trials) and "Leukemia" (7 trials). Many other conditions were trialed in "AnMed Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at AnMed Cancer Center
Most popular intervention types in "AnMed Cancer Center" are "Drug" (66 trials), "Other" (29 trials), "Biological" (21 trials), "Radiation" (18 trials) and "Procedure" (11 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (18 trials), "radiation therapy" (11 trials), "cyclophosphamide" (10 trials), "gemcitabine hydrochloride" (7 trials) and "prednisone" (7 trials). Other intervention names were less common.
Clinical Trials Genders at AnMed Cancer Center
The vast majority of trials in "AnMed Cancer Center" are
66 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at AnMed Cancer Center
Currently, there are NaN active trials in "AnMed Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 74 completed trials in AnMed Cancer Center,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in AnMed Cancer Center, 1 "Phase 1"
clinical trials were conducted, 41 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".